Back
Provident Bancorp Vs. Spyre Therapeutics Industry Stock Comparison
Buy
55
PVBC
Provident Bancorp
Last Price:
9.83
Seasonality Move:
-0.02%
Sell
27
SYRE
Spyre Therapeutics
Last Price:
23.13
Seasonality Move:
49.76%
Buy
55
Provident Bancorp (PVBC)
is a Buy
Is Provident Bancorp a Buy, Sell or Hold?
- The current Provident Bancorp [PVBC] share price is $9.67. The Score for PVBC is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- PVBC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $22.90. The Score for SYRE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- SYRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PVBC Stock Price Chart
What is Provident Bancorp's stock price today?
-
The Provident Bancorp share price today is $9.67
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PVBC is experiencing selling pressure, which indicates risk of future bearish movement.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $22.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.
PVBC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.1 | Buy |
Relative Strength Index (14 RSI): | 51.72 | Buy |
Chaikin Money Flow: | -23104 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.39 - 9.91) | Buy |
Bollinger Bands (100): | (8.72 - 10.04) | Buy |
SYRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.94 | Sell |
Relative Strength Index (14 RSI): | 28.27 | Sell |
Chaikin Money Flow: | -408420 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.66 - 36.8) | Sell |
Bollinger Bands (100): | (27.1 - 39.22) | Sell |
PVBC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.74 | Sell |
20-day SMA: | 9.72 | Sell |
50-day SMA: | 9.27 | Buy |
200-day SMA: | 9.63 | Buy |
8-day EMA: | 9.74 | Sell |
20-day EMA: | 9.68 | Sell |
50-day EMA: | 9.49 | Buy |
200-day EMA: | 9.51 | Buy |
SYRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.49 | Sell |
20-day SMA: | 31.58 | Sell |
50-day SMA: | 33.73 | Sell |
200-day SMA: | 24.46 | Sell |
8-day EMA: | 26.49 | Sell |
20-day EMA: | 30.15 | Sell |
50-day EMA: | 32.53 | Sell |
200-day EMA: | 27.05 | Sell |
Provident Bancorp Earnings Growth & PVBC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.03 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.
Provident Bancorp Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Spyre Therapeutics Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |